BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24529874)

  • 61. Might testosterone actually reduce mortality?
    Snyder PJ
    J Clin Endocrinol Metab; 2008 Jan; 93(1):32-3. PubMed ID: 18178907
    [No Abstract]   [Full Text] [Related]  

  • 62. Testosterone and Cardiovascular Disease in Men.
    Zhao D; Guallar E
    Ann Intern Med; 2022 Feb; 175(2):287-288. PubMed ID: 34958604
    [No Abstract]   [Full Text] [Related]  

  • 63. [About Clinical Trials of a Cardiac Hormone in Cardiovascular Conditions in General Practice].
    DAVID P
    Union Med Can; 1946 Jul; 75():835. PubMed ID: 20990217
    [No Abstract]   [Full Text] [Related]  

  • 64. A critical analysis of testosterone supplementation therapy and cardiovascular risk in elderly men.
    Scovell J; Ramasamy R; Kovac JR
    Can Urol Assoc J; 2014 May; 8(5-6):E356-7. PubMed ID: 24940464
    [No Abstract]   [Full Text] [Related]  

  • 65. Are men at risk? The role of testosterone in cardiovascular morbidity.
    Sundivakkam PC; Desai AA; Smith KA; Yuan JX
    Pulm Circ; 2012 Jul; 2(3):275-7. PubMed ID: 23130097
    [No Abstract]   [Full Text] [Related]  

  • 66. CORRIGENDUM FOR "The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials".
    J Clin Endocrinol Metab; 2020 Jan; 105(1):384-5. PubMed ID: 31832674
    [No Abstract]   [Full Text] [Related]  

  • 67. MEN, RESEARCH AND OPPORTUNITY.
    MCMICHAEL J
    Listing Res Cardiovasc Field; 1964; 10():12-4. PubMed ID: 24547392
    [No Abstract]   [Full Text] [Related]  

  • 68. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
    Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association of Serum Testosterone and Luteinizing Hormone With Blood Pressure and Risk of Cardiovascular Disease in Middle-Aged and Elderly Men.
    Qu M; Feng C; Wang X; Gu Y; Shang X; Zhou Y; Xiong C; Li H
    J Am Heart Assoc; 2021 Apr; 10(7):e019559. PubMed ID: 33739129
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association between dehydroepiandrosterone levels and cardiovascular risk in public sector health workers in a Peruvian region.
    Rojas RJ; Chávez-Sosa JV; Gutierrez-Ajalcriña R; Huancahuire-Vega S
    Cardiovasc Endocrinol Metab; 2021 Mar; 10(1):51-55. PubMed ID: 33634256
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Testosterone antagonizes paraquat-induced cardiomyocyte senescence via the mIGF-1/SIRT1 signaling pathway.
    Yu X; Zheng J; Cai T; Wang Z; Zhu G
    Braz J Med Biol Res; 2020; 53(10):e9849. PubMed ID: 32901689
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS).
    Rochira V; Mossetto G; Jia N; Cannavo S; Beck-Peccoz P; Aimaretti G; Ambrosio MR; Di Somma C; Losa M; Ferone D; Lubrano C; Scaroni C; Giampietro A; Corsello SM; Poggi M
    J Endocrinol Invest; 2018 Nov; 41(11):1259-1266. PubMed ID: 29536433
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Therapeutic Efficacy of an ω-3-Fatty Acid-Containing 17-β Estradiol Nano-Delivery System against Experimental Atherosclerosis.
    Deshpande D; Kethireddy S; Janero DR; Amiji MM
    PLoS One; 2016; 11(2):e0147337. PubMed ID: 26840601
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hormones and health outcomes in aging men.
    Yeap BB
    Exp Gerontol; 2013 Jul; 48(7):677-81. PubMed ID: 22884846
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Androgens and cardiovascular disease.
    Yeap BB
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):269-76. PubMed ID: 20186051
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In older men, higher plasma testosterone or dihydrotestosterone is an independent predictor for reduced incidence of stroke but not myocardial infarction.
    Yeap BB; Alfonso H; Chubb SA; Hankey GJ; Handelsman DJ; Golledge J; Almeida OP; Flicker L; Norman PE
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4565-73. PubMed ID: 25268392
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sex steroids and cardiovascular disease.
    Yeap BB
    Asian J Androl; 2014; 16(2):239-47. PubMed ID: 24407188
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death.
    Rodondi N; Newman AB; Vittinghoff E; de Rekeneire N; Satterfield S; Harris TB; Bauer DC
    Arch Intern Med; 2005 Nov; 165(21):2460-6. PubMed ID: 16314541
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hormones and cardiovascular disease in older men.
    Yeap BB; Flicker L
    J Am Med Dir Assoc; 2014 May; 15(5):326-33. PubMed ID: 24529874
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.